- Advertisement -

TAG

Pacific Biosciences of California Inc.

Companies

why Pacific Biosciences of California Inc. [PACB] is a Good Choice for Investors After New Price Target of $18.40

Caleb Clifford - January 15, 2021 0

Pacific Biosciences of California Inc. jumped around 3.37 points on Thursday, while shares priced at $37.72 at the close of the session, up...

Finance

why Pacific Biosciences of California Inc. [PACB] is a Good Choice for Investors After New Price Target of $17.40

Edison Baldwin - December 15, 2020 0

Pacific Biosciences of California Inc. price plunged by -1.16 percent to reach at -$0.25. The company report on December 14, 2020 that Leading...

Finance

Piper Sandler slashes price target on Pacific Biosciences of California Inc. [PACB] – find out why.

Annabelle Farmer - November 30, 2020 0

Pacific Biosciences of California Inc. traded at a high on 11/27/20, posting a 6.12 gain after which it closed the day’ session at...

Finance

Pacific Biosciences of California Inc. [PACB] moved up 12.35: Why It’s Important

Edison Baldwin - November 12, 2020 0

Pacific Biosciences of California Inc. gained 12.35% on the last trading session, reaching $16.47 price per share at the time. The company report...

Market

why Pacific Biosciences of California Inc. [PACB] is a Good Choice for Investors After New Price Target of $13.20

Misty Lee - October 28, 2020 0

Pacific Biosciences of California Inc. gained 4.95% or 0.69 points to close at $14.64 with a heavy trading volume of 2123773 shares. The...

Market

Pacific Biosciences of California Inc. [PACB] stock Upgrade by JP Morgan analyst, price target now $15

Caleb Clifford - October 13, 2020 0

Pacific Biosciences of California Inc. stock went on a downward path that fall over -2.81% on Monday, amounting to a one-week price increase...

Market

Market cap of Pacific Biosciences of California Inc. [PACB] reaches 1.55B – now what?

Annabelle Farmer - September 28, 2020 0

Pacific Biosciences of California Inc. stock went on an upward path that rose over 3.82% on Friday, amounting to a one-week price increase...

Finance

Market cap of Pacific Biosciences of California Inc. [PACB] reaches 1.19B – now what?

Caleb Clifford - September 11, 2020 0

Pacific Biosciences of California Inc. closed the trading session at $6.97 on 09/10/20. The day’s price range saw the stock hit a low...

Finance

Pacific Biosciences of California Inc. [PACB] is 25.49% higher this YTD. Is it still time to buy?

Brandon Evans - August 26, 2020 0

Pacific Biosciences of California Inc. price plunged by -3.15 percent to reach at -$0.21. The company report on August 12, 2020 that Pacific...

Industry

Pacific Biosciences of California Inc. [PACB] moved down -0.42: Why It’s Important

Caleb Clifford - August 11, 2020 0

Pacific Biosciences of California Inc. closed the trading session at $4.71 on 08/10/20. The day’s price range saw the stock hit a low...

12 Page 1 of 2

Latest news

Industry

H.C. Wainwright lifts Diffusion Pharmaceuticals Inc. [DFFN] price estimate. Who else is bullish?

Brandon Evans - January 22, 2021 0

Diffusion Pharmaceuticals Inc. gained 8.41% or 0.09 points to close at $1.16 with a heavy trading volume of 5001331 shares. The company report...

Finance

Infosys Limited [INFY] is 7.37% higher this YTD. Is it still time to buy?

Annabelle Farmer - January 22, 2021 0

Infosys Limited closed the trading session at $18.20 on 01/21/21. The day’s price range saw the stock hit a low of $18.15, while...

Companies

Ruhnn Holding Limited [RUHN] Revenue clocked in at $191.40 million, up 13.36% YTD: What’s Next?

Misty Lee - January 22, 2021 0

Ruhnn Holding Limited jumped around 0.26 points on Thursday, while shares priced at $3.31 at the close of the session, up 8.52%. The...

Market

Hyliion Holdings Corp. [HYLN] Is Currently 5.41 below its 200 Period Moving Avg: What Dose This Mean?

Edison Baldwin - January 22, 2021 0

Hyliion Holdings Corp. stock went on an upward path that rose over 5.41% on Thursday, amounting to a one-week price increase of more...

Industry

Merus N.V. [MRUS] moved up 8.75: Why It’s Important

Caleb Clifford - January 22, 2021 0

Merus N.V. gained 8.75% on the last trading session, reaching $27.22 price per share at the time. The company report on January 21,...

- Advertisement -

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Pacific Biosciences of California Inc.

Latest news

H.C. Wainwright lifts Diffusion Pharmaceuticals Inc. [DFFN] price estimate. Who else is bullish?

Infosys Limited [INFY] is 7.37% higher this YTD. Is it still time to buy?

Ruhnn Holding Limited [RUHN] Revenue clocked in at $191.40 million, up 13.36% YTD: What’s Next?

Hyliion Holdings Corp. [HYLN] Is Currently 5.41 below its 200 Period Moving Avg: What Dose This Mean?

Merus N.V. [MRUS] moved up 8.75: Why It’s Important

Get The Best Stocks To Trade Every Day!

Editor Picks

PACCAR Inc (PCAR) Deal allows Aurora Autonomous Truck Validation

Why Stratasys Ltd. (SSYS) Share Jumped over 12%?

Popular Category